TY  - CHAP
M1  - Book, Section
TI  - Polycythemia Vera
A1  - Damon, Lloyd E.
A1  - Andreadis, Charalambos Babis
A2  - Papadakis, Maxine A.
A2  - McPhee, Stephen J.
A2  - Rabow, Michael W.
A2  - McQuaid, Kenneth R.
PY  - 2022
T2  - Current Medical Diagnosis & Treatment 2022
AB  - Key  Clinical  Updates  in  Polycythemia  VeraRopeginterferon  alfa-2b  was  approved  by  the  European  Medicines  Agency  as  first-line  therapy  for  patients  with  polycythemia  vera  without  symptomatic  splenomegaly.  
SN  - 
PB  - McGraw-Hill Education
CY  - New York, NY
Y2  - 2024/04/20
UR  - accessmedicine.mhmedical.com/content.aspx?aid=1184166012
ER  -